SCHEMBL30278909

SCHEMBL30278909

COc1ccc(C(=O)N2CCC(CC3CCNCC3)CC2)cc1N1CCC(=O)NC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ HSD11B1 P28845 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ SOS1 Q07889 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TPSAB1 Q15661 1/20 0.39
▸ TPSD1 Q9BZJ3 1/20 0.39
▸ TPSG1 Q9NRR2 1/20 0.39
▸ TNKS O95271 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ PARP10 Q53GL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31255281 0.95 SOS1 (0.44) NR3C1PGRSLC6A4KCNH2PDE3B
Trifluoroacetic Acid SCHEMBL31255582 0.94 PKM (0.45) NR3C1PGRSLC6A4KCNH2PDE3B
SCHEMBL31586070 0.91 NR3C1 (0.43) NR3C1PGRSLC6A4KCNH2PDE3B
SCHEMBL31255602 0.91 L3MBTL3 (0.44) NR3C1PGRSLC6A4KCNH2PDE3B
SCHEMBL25581203 0.91 NR3C1 (0.43) NR3C1PGRSLC6A4KCNH2PDE3B
Trifluoroacetic Acid SCHEMBL31255689 0.90 SOS1 (0.46) NR3C1PGRSLC6A4KCNH2PDE3B
Trifluoroacetic Acid SCHEMBL31255728 0.90 PKM (0.46) NR3C1PGRSLC6A4KCNH2PDE3B
SCHEMBL31447662 0.89 SOS1 (0.44) NR3C1PGRSLC6A4KCNH2PDE3B
SCHEMBL27137025 0.89 RBP4 (0.38) NR3C1PGRSLC6A4KCNH2PDE3B
Hydrochloric Acid SCHEMBL30278940 0.88 SOS1 (0.45) NR3C1PGRSLC6A4KCNH2PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720044-A1 AROMATIC AMIDES AND CONJUGATES THEREOF AS BINDERS TO TEAD Beactica Therapeutics AB (SE) 2026-04-08 — — EP disclosed
WO-2024240840-A1 AROMATIC AMIDES AND CONJUGATES THEREOF AS BINDERS TO TEAD BEACTICA THERAPEUTICS AB (SE) 2024-11-28 — — WO disclosed
US-20240382600-A1 BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER NOVARTIS AG (CH) 2024-11-21 — — US disclosed
EP-4395828-A1 BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER Novartis AG (CH) 2024-07-10 — — EP disclosed
WO-2023031801-A1 BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER NOVARTIS AG (CH) 2023-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240382600-A1 BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER YAP1, JMJD7, TOR1AIP1 NR3C1 3889/4885PGR 4303/4885SLC6A4 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback